N-TERMINAL ANTHRANOYL-PHENYLALANINE DERIVATIVES AS CCK1 RECEPTOR ANTAGONISTS: THE FINAL APPROACH
•
LASSIANI, LUCIA
•
VALENTA V
altro
MAKOVEC F.
2005
Periodico
MEDICINAL CHEMISTRY
Abstract
Starting from our lead compound, VL-0395, an anthranilic acid based CCK1 receptor antagonist and following the well established “step by step” lead investigation strategy, we describe the final step of the anthranilic acid N-terminal optimization.
Archivio
Diritti
metadata only access
Soggetti